TY - JOUR
KW - 2580:Psychopharmacology
KW - 3290:Physical & Somatoform & Psychogenic Disorders
KW - abuse
KW - Addiction
KW - Analgesics, Opioid
KW - article
KW - Drug Abuse
KW - Drug Addiction
KW - Human
KW - Humans
KW - Opiates
KW - Opioids
KW - pain
KW - Pain Management
KW - prescriptions
KW - Risk Assessment
KW - risk screening
KW - Screening
KW - Substance-Related Disorders
AU - Steven D. Passik
AU - Kenneth L. Kirsh
A1 - 
BT - Experimental and clinical psychopharmacology
C5 - Opioids & Substance Use
CP - 5
IS - 5
JF - Experimental and clinical psychopharmacology
PB - American Psychological Association
PY - 2008
SN - 1064-1297, 1064-1297
SP - 400
EP - 404
EP - 
T1 - The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse
T2 - Experimental and clinical psychopharmacology
TI - The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse
U1 - Opioids & Substance Use
VL - 16
VO - 1064-1297, 1064-1297
Y1 - 2008
ER -